Breaking News, Financial News

Financial Report: AmerisourceBergen

Revenues up 28% in the quarter

AmerisourceBergen

4Q Revenues: $24.5 billion (+28%)

4Q Earnings: $51.0 million (-69%)

FY Revenues: $88.0 billion (+13%)

FY Earnings: $433.7 million (-40%)

Comments: Growth in the quarter reflects a 34% increase in AmerisourceBergen Drug Corp. (ABDC) revenue, and a 12% increase in AmerisourceBergen Specialty Group (ABSG) revenue. Pharmaceutical Distribution revenues were $24.1 billion, up 29%. Earnings reflect discontinued operations from AndersonBrecon and AmerisourceBergen Canada Corp., both of which were divested in 3Q13.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters